Evidence map›Paper›PMID 29712423›Full record

ArticleJournal of the American Chemical Society2018

Readily Accessible Ambiphilic Cyclopentadienes for Bioorthogonal Labeling.

Brian J Levandowski, Raymond F Gamache, Jennifer M Murphy, K N Houk

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Computational study of an oxetane 4Tetrahedron letters · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Differential Effects of Nitrogen Substitution in 5- and 6-Membered Aromatic Motifs.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Brian J LevandowskiDepartment of Chemistry and Biochemistry , University of California , Los Angeles , California 90095 , United States.ORCID 0000-0002-8139-9417
Raymond F GamacheDepartment of Chemistry and Biochemistry , University of California , Los Angeles , California 90095 , United States.
Jennifer M MurphyDepartment of Molecular and Medical Pharmacology and Crump Institute for Molecular Imaging, David Geffen School of Medicine , University of California , Los Angeles , California 90095 , United States.ORCID 0000-0002-8492-4918
K N HoukDepartment of Chemistry and Biochemistry , University of California , Los Angeles , California 90095 , United States.ORCID 0000-0002-8387-5261

Funding

Bioorthogonal CycloadditionsR01GM109078 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HOUK, KENDALL N · 2015 to 2018
$1.1M
NIGMS NIH HHS R01 GM109078
6 · The paper itself

Abstract

A new class of bioorthogonal reagents based on the cyclopentadiene scaffold is described. The diene 6,7,8,9-tetrachloro-1,4-dioxospiro[4,4]nona-6,8-diene (a tetrachlorocyclopentadiene ketal, TCK) is ambiphilic and self-orthogonal with remarkable stability. The diene reacts rapidly with a trans-cyclooctene and an endo-bicyclononyne, but slowly with dibenzoazacyclooctyne (DIBAC), allowing for tandem labeling studies with mutually orthogonal azides that react rapidly with DIBAC. TCK analogues are synthesized in three steps from inexpensive, commercially available starting materials.

Indexed as

AzidesChemistry Techniques, SyntheticCyclooctanesCyclopentanesHalogenationIndicators and ReagentsStaining and LabelingAzidesCyclooctanesCyclopentanesIndicators and Reagents

Identifiers

PMID29712423
PMCPMC6314806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.